September 2023 - Rapid Dosimetry

Rapid’s, FDA-cleared dosimetry software, 3D-RD-S, Receives CE Mark Approval, Expanding Global Access to Cutting-Edge Radiopharmaceutical Dosimetry Software

Post author:Rapid Dosimetry
Post published:September 6, 2023
Post category:rapid dosimetry

Baltimore, Maryland, – Rapid®, a trailblazer in quantitative imaging and dosimetry solutions, is proud to announce the approval of the CE mark for its dosimetry software, 3D-RD-S. This significant achievement…

About company

Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid) is a Baltimore-based company providing comprehensive expert service and software solutions related to quantitative imaging, dosimetry, in support of pre-clinical and clinical studies needed for regulatory approval and for the maximally effective and safe clinical implementation of radiopharmaceuticals.

BE THE FIRST TO KNOW WHEN 3D-RD-S IS RELEASED

BE THE FIRST TO KNOW WHEN 3D-RD-S IS RELEASED

Rapid’s, FDA-cleared dosimetry software, 3D-RD-S, Receives CE Mark Approval, Expanding Global Access to Cutting-Edge Radiopharmaceutical Dosimetry Software